Cefazolin continuous vs. intermittent for wound infection after heart bypass surgery
Treatments studied
Part of Infections clinical trials.
This trial tests whether giving the antibiotic cefazolin as a steady drip (continuous infusion) works better than giving it in quick doses (intermittent bolus) to prevent infections after coronary artery bypass graft (CABG) surgery. It is for Egyptian patients who are admitted to the cardiothoracic ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having coronary artery bypass graft (CABG) surgery using a heart-lung machine (cardiopulmonary bypass).
- You are admitted to the cardiothoracic intensive care unit (ICU) after surgery.
- You are not taking medications that weaken your immune system.
- You are not pregnant or breastfeeding.
- You are willing and able to follow the study's treatment schedule and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of giving the antibiotic cefazolin during major orthopedic surgery: as a continuous drip (through an IV line over hours) versus as short shots (boluses) at certain times. The goal is to see which method better prevents infections at the surgical site.
This trial tests if injecting levofloxacin (a type of antibiotic) just under the skin around the surgical cut helps prevent infections in emergency belly surgery. If you are having an emergency operation on your abdomen and your surgery is considered contaminated or dirty (like from a burst appendix or a bowel perforation), you may be eligible.
This study looks at how long patients should receive an antibiotic after certain types of heart surgery, to help prevent infections. It may help find the best “duration” of antibiotic prophylaxis after surgery through the breastbone (median sternotomy).
This trial tests different antibiotics given before open-heart surgery to see which works best to prevent infections. It could help you if you're having heart surgery and want to lower your risk of getting an infection afterward.
This trial tests two ways of giving the antibiotic ceftazidime/avibactam (a powerful drug for resistant bacteria) to critically ill patients in the ICU. The goal is to see if a continuous infusion works better than standard timed doses.
This trial tests whether giving the antibiotic ceftazidime-avibactam continuously or intermittently works better for ICU patients with severe infections caused by drug-resistant bacteria. The goal is to see which method improves outcomes.
Hear when a new Surgical Site Infection (SSI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.